×

Amide Proton Transfer Imaging seems to provide Higher Diagnostic Performance in Post-treatment High-grade Gliomas than Methionine Positron Emission Tomography
Clinical significance of visually equivocal amyloid PET findings from the Alzheimer's Disease Neuroimaging Initiative cohort.
Detrimental effect of type 2 diabetes mellitus in a large case series of Parkinson's disease.
Differences in gray and white matter 18F-THK5351 uptake between behavioral-variant frontotemporal dementia and other dementias.
Does Late Levodopa Administration Delay the Development of Dyskinesia in Patients with De Novo Parkinson's Disease?
Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction.
Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease.
Head to head comparison of [(18)F] AV-1451 and [(18)F] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia.
Longitudinal cortical thinning and cognitive decline in patients with early- versus late-stage subcortical vascular mild cognitive impairment.
Pre-treatment metabolic tumor volume predicts tumor metastasis and progression in high-grade salivary gland carcinoma.
Prediction of distant metastasis and survival in adenoid cystic carcinoma using quantitative (18)F-FDG PET/CT measurements.
Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease.
Prognostic value of 18 F-FDG PET/CT parameters in patients who undergo salvage treatments for recurrent squamous cell carcinoma of the larynx and hypopharynx.
Putaminal dopamine depletion in de novo Parkinson's disease predicts future development of wearing-off.
The Pattern of Striatal Dopamine Depletion as a Prognostic Marker in De Novo Parkinson Disease.
The presence of depression in de novo Parkinson's disease reflects poor motor compensation.
(18) F-FDG PET/CT vs. human papillomavirus, p16 and Epstein-Barr virus detection in cervical metastatic lymph nodes for identifying primary tumors.
18F-FDG PET/CT Versus Contrast-Enhanced CT for Staging and Prognostic Prediction in Patients With Salivary Gland Carcinomas.
Asymmetry of cerebral glucose metabolism in very low-birth-weight infants without structural abnormalities.
Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer's disease, subjects with amnestic mild cognitive impairment and healthy volunteers.
Different subregional metabolism patterns in patients with cerebellar ataxia by 18F-fluorodeoxyglucose positron emission tomography.
Longitudinal Decline of Striatal Subregional [(18)F]FP-CIT Uptake in Parkinson's Disease.
Lymph node standardized uptake values at pre-treatment (18)F-fluorodeoxyglucose positron emission tomography as a valuable prognostic factor for distant metastasis in nasopharyngeal carcinoma.
Protective effects of APOE e2 against disease progression in subcortical vascular mild cognitive impairment patients: A three-year longitudinal study.
Regional amyloid burden and lacune in pure subcortical vascular cognitive impairment.
Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET.
(18)F FDG PET/CT versus CT/MR Imaging and the Prognostic Value of Contralateral Neck Metastases in Patients with Head and Neck Squamous Cell Carcinoma
18F-FDG PET/CT surveillance for the detection of recurrence in patients with head and neck cancer
Additional Value of Early-Phase 18F-FP-CIT PET Image for Differential Diagnosis of Atypical Parkinsonism.